Retrospective immunohistochemical analysis of the primary CNS tumor showed the SHH-MB immunophenotype [12], which was further confirmed by retrospective CGH array and targeted next-generation sequencing showing chromosome 9q copy neutral-loss of heterozygosity and the PTCH1 mutation, respectively (Table 1, Figure 3). This evidence concerns the gene PTCH1 and central nervous system neoplasm.